Literature DB >> 12780928

Rectal flap advancement--a simple and effective approach for the treatment of rectourethral fistula.

Z Dreznik1, D Alper, T H Vishne, E Ramadan.   

Abstract

OBJECTIVE: Rectourethral fistula is a rare complication of prostatic surgery and other pelvic procedures. We report our experience of surgical repair of using a rectal advancement flap. PATIENTS: Three patients with rectourethral fistula following prostatic surgery were treated. Two patients had an anterior partial thickness of rectal flap advancement via a trans-anal approach without urinary or faecal diversion. In one patient a rectal flap repair was performed through a posterior transsphincteric approach following urinary and faecal diversion.
RESULTS: No significant postoperative complications occurred. Healing was successful in each patient and faecal and urinary continence was normal.
CONCLUSION: Transanal rectal advancement flap is a simple and effective technique for the treatment of a rectourethral fistula with no need for urinary or faecal diversion.

Entities:  

Mesh:

Year:  2003        PMID: 12780928     DOI: 10.1046/j.1463-1318.2003.00400.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Urinary tract injures: recognition and management.

Authors:  Scott E Delacroix; J C Winters
Journal:  Clin Colon Rectal Surg       Date:  2010-06

2.  Rectourethral fistula following laparoscopic radical prostatectomy.

Authors:  L Chun; M A Abbas
Journal:  Tech Coloproctol       Date:  2011-07-01       Impact factor: 3.781

Review 3.  Management of Complex Perineal Fistula Disease.

Authors:  Ricardo Tadayoshi Akiba; Fabio Gontijo Rodrigues; Giovanna da Silva
Journal:  Clin Colon Rectal Surg       Date:  2016-06

4.  [Fistula surgery].

Authors:  C M Rosenbaum; M W Vetterlein; M Fisch
Journal:  Urologe A       Date:  2020-04       Impact factor: 0.639

5.  Surgical Treatment of Iatrogenic Rectourinary Fistula-York-Mason Technique-a Case Report.

Authors:  Pedro Bargão Santos; Fernando Ferrito; Rocha Pires
Journal:  ISRN Urol       Date:  2011-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.